213 related articles for article (PubMed ID: 35957912)
1. A distinct lipid metabolism signature of acute myeloid leukemia with prognostic value.
Li D; Liang J; Yang W; Guo W; Song W; Zhang W; Wu X; He B
Front Oncol; 2022; 12():876981. PubMed ID: 35957912
[TBL] [Abstract][Full Text] [Related]
2. A novel prognostic classification integrating lipid metabolism and immune co-related genes in acute myeloid leukemia.
Li D; Wu X; Cheng C; Liang J; Liang Y; Li H; Guo X; Li R; Zhang W; Song W
Front Immunol; 2023; 14():1290968. PubMed ID: 38022627
[TBL] [Abstract][Full Text] [Related]
3. A Comprehensive Metabolism-Related Gene Signature Predicts the Survival of Patients with Acute Myeloid Leukemia.
Zhai Y; Shen H; Wei H
Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254953
[TBL] [Abstract][Full Text] [Related]
4. Identification of an Immune-Related Gene Signature Based on Immunogenomic Landscape Analysis to Predict the Prognosis of Adult Acute Myeloid Leukemia Patients.
Zhu R; Tao H; Lin W; Tang L; Hu Y
Front Oncol; 2020; 10():574939. PubMed ID: 33330048
[TBL] [Abstract][Full Text] [Related]
5. Integrated bioinformatic analysis of mitochondrial metabolism-related genes in acute myeloid leukemia.
Tong X; Zhou F
Front Immunol; 2023; 14():1120670. PubMed ID: 37138869
[TBL] [Abstract][Full Text] [Related]
6. Identification of m6A-Related lncRNAs Associated With Prognoses and Immune Responses in Acute Myeloid Leukemia.
Li D; Liang J; Cheng C; Guo W; Li S; Song W; Song Z; Bai Y; Zhang Y; Wu X; Zhang W
Front Cell Dev Biol; 2021; 9():770451. PubMed ID: 34869365
[No Abstract] [Full Text] [Related]
7. Construction of a Pyroptosis-Related Signature for Prognostic Prediction and Characterization of Immune Microenvironment in Acute Myelogenous Leukemia.
Liu S; Luo D; Luo J; Liang H; Zhi Y; Wang D; Xu N
Int J Gen Med; 2022; 15():2913-2927. PubMed ID: 35308573
[TBL] [Abstract][Full Text] [Related]
8. Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia.
Yang Y; Yang Y; Liu J; Zeng Y; Guo Q; Guo J; Guo L; Lu H; Liu W
Front Immunol; 2022; 13():1038570. PubMed ID: 36544784
[TBL] [Abstract][Full Text] [Related]
9. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature.
Fu D; Zhang B; Wu S; Zhang Y; Xie J; Ning W; Jiang H
Front Immunol; 2021; 12():695865. PubMed ID: 34135913
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Mitochondria-Related Gene Signature to Predict the Prognosis in AML.
Jiang N; Zhang X; Chen Q; Kantawong F; Wan S; Liu J; Li H; Zhou J; Lu B; Wu J
Front Oncol; 2022; 12():823831. PubMed ID: 35359394
[TBL] [Abstract][Full Text] [Related]
11. Systematic Analysis of Autophagy-Related Signature Uncovers Prognostic Predictor for Acute Myeloid Leukemia.
Chen XX; Li ZP; Zhu JH; Xia HT; Zhou H
DNA Cell Biol; 2020 Sep; 39(9):1595-1605. PubMed ID: 32783661
[TBL] [Abstract][Full Text] [Related]
12. A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia.
Zhang HB; Sun ZK; Zhong FM; Yao FY; Liu J; Zhang J; Zhang N; Lin J; Li SQ; Li MY; Jiang JY; Cheng Y; Xu S; Cheng XX; Huang B; Wang XZ
Lipids Health Dis; 2022 Aug; 21(1):79. PubMed ID: 36002858
[TBL] [Abstract][Full Text] [Related]
13. Immune-related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia.
Xu Q; Cao D; Fang B; Yan S; Hu Y; Guo T
Cancer Med; 2022 Sep; 11(17):3364-3380. PubMed ID: 35355427
[TBL] [Abstract][Full Text] [Related]
14. Identification and analysis of methylation signature genes and association with immune infiltration in pediatric acute myeloid leukemia.
Zhu H; Xu Y; Xia J; Guo X; Fang Y; Fan J; Li F; Wu J; Zheng G; Liu Y
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14965-14982. PubMed ID: 37606761
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of an Individualized Metabolism-Related Prognostic Model for Adult Acute Myeloid Leukemia Patients.
Wei C; Ding L; Luo Q; Li X; Zeng X; Kong D; Yu X; Feng J; Ye Y; Wang L; Huang H
Front Oncol; 2022; 12():829007. PubMed ID: 35785164
[TBL] [Abstract][Full Text] [Related]
16. Construction and validation of an NAD + metabolism-related lncRNA signature for predicting the prognosis and immune landscape of acute myeloid leukemia.
Zhu Y; Jian J; Niu Y; Yang X; Guo Y; Zhao L; Liu B
Hematology; 2023 Dec; 28(1):2231760. PubMed ID: 37417449
[TBL] [Abstract][Full Text] [Related]
17. A novel 4-mRNA signature predicts the overall survival in acute myeloid leukemia.
Chen Z; Song J; Wang W; Bai J; Zhang Y; Shi J; Bai J; Zhou Y
Am J Hematol; 2021 Nov; 96(11):1385-1395. PubMed ID: 34339537
[TBL] [Abstract][Full Text] [Related]
18. A Novel Fatty Acid Metabolism-Associated Risk Model for Prognosis Prediction in Acute Myeloid Leukaemia.
Wang N; Bai X; Wang X; Wang D; Ma G; Zhang F; Ye J; Lu F; Ji C
Curr Oncol; 2023 Feb; 30(2):2524-2542. PubMed ID: 36826154
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.
Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720
[TBL] [Abstract][Full Text] [Related]
20. Construction and validation of a fatty acid metabolism risk signature for predicting prognosis in acute myeloid leukemia.
Chen M; Tao Y; Yue P; Guo F; Yan X
BMC Genom Data; 2022 Dec; 23(1):85. PubMed ID: 36550404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]